Could inflammation predict who benefits from magic mushroom therapy?
NCT ID NCT07164755
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study examines blood samples from 46 people with treatment-resistant depression who took psilocybin in a previous trial. Researchers will measure markers of inflammation (cytokines and mRNA) to see if they relate to how well the treatment worked. The goal is to understand whether inflammation levels before or after treatment can predict who gets better, which could help personalize psychedelic therapy.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors predict who will benefit from psilocybin therapy and point toward new ways to treat depression by targeting inflammation.
- What could go wrong
- This is a small, observational analysis of existing samples, not a new treatment trial. It may not find clear links between inflammation and depression outcomes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
King's College London Institute of Psychiatry, Psychology and Neuroscience
London, SE5 8AF, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who returns to work after stress treatment?
- Can a Parent-Targeted program ease Kids' behavior problems when depression is in the picture?
- A Two-Year watch: can brain scans and surveys predict depression and anxiety in teens?
- Can a Three-Session therapy rival CBT for Event-Related depression?
- Your genes could hold the key to better depression treatment
- A therapy that aims to boost wellbeing, not just ease symptoms — a trial puts it to the test